Oskar Hansson
21 – 30 of 628
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
- Contribution to journal › Article
-
Mark
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals
- Contribution to journal › Article
-
Mark
Long-term exposure to air pollution and validated cases of Alzheimer's disease and vascular dementia in the Malmö diet and cancer cohort
- Contribution to journal › Article
-
Mark
Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes
- Contribution to journal › Article
-
Mark
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease
- Contribution to journal › Article
-
Mark
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease : A Meta-Analysis
- Contribution to journal › Article
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
The CentiMarker project : Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretation
- Contribution to journal › Article
-
Mark
A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease
- Contribution to journal › Article
